Skye Bioscience SKYE Cash Flow Statement (2012-2026)

NASDAQ SKYE
$2.23 +0.35 (+18.62%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Skye Bioscience Quarterly Cash Flow Statement

Periods 58 quarters
Latest Jun 2026

Skye Bioscience reported cash from operations of -$7.12M and free cash flow of -$7.09M for the quarter ended Jun 2026, up 33.7% year over year. This cash flow statement covers 58 quarters of results from Apr 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Dec2013 Apr2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-1.82M-2.51M-3.04M-3.42M-3.13M-9.89M-5.17M-3.11M-24.95M-4.42M-5.02M-7.90M-3.90M-9.75M-11.10M-17.62M-12.75M-14.44M-12.51M-10.79M
Share-based Compensation
0.49M0.12M0.14M0.14M0.14M0.20M0.13M0.10M0.16M0.59M2.48M1.83M1.92M2.09M2.20M2.03M1.91M1.62M1.50M1.27M
Gains from Investment Securities
-0.04M-0.01M-0.01M-323.00-3.00
Cash from Operations
-1.49M-1.97M-2.91M-2.90M-2.06M-4.87M-4.06M-1.99M-4.05M-3.84M-4.71M-7.09M-5.26M-8.17M-9.19M-10.75M-13.36M-9.77M-8.56M-7.12M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
0.17M1.00
Amortization of Deferred Charges
420.000.15M0.15M444.00459.000.01M0.00M0.23M0.24M0.01M0.00M
Depreciation & Amortization (CF)Depreciation & Amortization
0.03M0.03M0.07M0.18M0.18M0.19M0.18M0.18M0.17M0.16M
Change in Working Capital
Change in Receivables
Change in Account Payables
-0.09M0.61M0.02M0.08M0.27M0.32M-0.45M0.33M0.00M-0.46M-0.06M-0.02M-0.30M-0.21M1.22M1.37M-0.40M-0.79M1.90M0.34M
Change in Accured Expenses
-0.16M0.08M-0.11M0.19M0.04M-1.97M0.13M0.12M-0.83M0.08M-0.53M0.20M1.44M-1.45M-0.46M2.08M0.39M0.29M1.21M-2.79M
Change in Taxes
Other Working Capital Changes
0.06M-0.14M-0.02M-0.02M-0.02M-0.02M0.00M-0.05M-0.01M-0.02M-0.02M-0.02M-0.02M-0.04M-0.04M-0.04M-0.05M-0.05M-0.21M-0.03M
Investing Activities
Capital Expenditures
0.03M0.05M0.00M0.76M0.19M-0.85M0.00M0.00M0.01M0.00M0.03M1.52M0.05M0.01M-0.02M-0.03M
Sales of Property, Plant and Equipment
5.53M1.15M0.07M850.00
Acquisitions
5.31M
Divestments
1.15M0.07M0.14M0.09M0.09M0.18M
Cash from Investing Activities
-0.03M-0.05M-0.00M-0.08M-0.37M5.67M5.53M1.07M-0.01M1.14M-0.03M-1.45M0.09M-12.81M-11.86M7.97M-2.80M10.90M7.14M
Financing Activities
Other financing activities
7.00M0.00M-0.00M0.28M-0.28M85.65M
Debt Issuance and Repayment
Long-Term Debt Issuances
-4.71M0.07M0.11M
Short-Term Debt issuances
0.06M0.09M0.09M0.44M0.05M0.12M0.07M-0.24M
Change in Capital Stock
Net Equity Issued and Repurchased
-6.76M-83.56M
Misc.
Cash from Financing Activities
7.42M-0.08M-0.06M-0.09M-0.09M0.03M-0.05M-0.12M16.63M-0.02M85.65M-2.10M0.01M0.02M0.01M-0.07M-0.10M
Change in Cash
5.90M-2.11M-2.98M-3.08M-2.51M0.83M1.42M-2.12M13.65M-3.87M82.09M-9.22M-6.71M-8.08M-21.99M-22.58M-5.40M-12.56M2.27M-0.08M
Free Cash Flow
-1.52M-2.02M-2.92M-3.66M-2.25M-4.02M-4.06M-1.99M-4.06M-3.85M-4.71M-7.13M-6.78M-8.22M-9.19M-10.75M-13.36M-9.77M-8.54M-7.09M
Net Cash Flow
5.90M-2.11M-2.98M-3.08M-2.51M0.83M1.42M-2.12M13.65M-3.87M82.09M-9.22M-6.71M-8.08M-21.99M-22.58M-5.40M-12.56M2.27M-0.08M